BLAZE-Limiting Approach in NMOSD
NCT06888622
·
clinicaltrials.gov ↗
COMPLETED
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Neuromyelitis Optica Spectrum Disorders (NMOSD)
Interventions
DRUG:
Eculizumab administration
Sponsor
Huashan Hospital